ASX:IDX Integral Diagnostics (IDX) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Integral Diagnostics Stock (ASX:IDX) 30 days 90 days 365 days Advanced Chart Get Integral Diagnostics alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume240,828 shsAverage VolumeN/AMarket CapitalizationA$1.10 billionP/E RatioN/ADividend Yield1.95%Price TargetN/AConsensus RatingN/A Company Overview Integral Diagnostics Limited, a healthcare services company, provides diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides services through 67 radiology clinics. The company was incorporated in 2008 and is headquartered in Melbourne, Australia. Read More Receive IDX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Integral Diagnostics and its competitors with MarketBeat's FREE daily newsletter. Email Address IDX Stock News HeadlinesIDX - Integral Diagnostics Ltd Price vs Fair Value - MorningstarJuly 1, 2025 | morningstar.comMWhy Macquarie forecasts a 22% upside for this ASX All Ords healthcare stockJune 27, 2025 | msn.comTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.July 9 at 2:00 AM | Porter & Company (Ad)These small cap ASX shares could rise 50% to 65%May 30, 2025 | msn.comShareholders in Integral Diagnostics (ASX:IDX) are in the red if they invested five years agoMay 26, 2025 | finance.yahoo.comIntegral Diagnostics Limited (ASX:IDX) Shares Could Be 44% Below Their Intrinsic Value EstimateApril 27, 2025 | finance.yahoo.com3 ASX Stocks Estimated To Be Up To 42.8% Below Intrinsic ValueApril 1, 2025 | uk.finance.yahoo.comIntegral Diagnostics Limited's (ASX:IDX) top owners are retail investors with 50% stake, while 44% is held by institutionsMarch 27, 2025 | finance.yahoo.comSee More Headlines IDX Stock Analysis - Frequently Asked Questions What other stocks do shareholders of Integral Diagnostics own? Based on aggregate information from My MarketBeat watchlists, some other companies that Integral Diagnostics investors own include electroCore (ECOR), Dynavax Technologies (DVAX), CytoDyn (CYDY), Credit Suisse Group (CS), Chimerix (CMRX), Capricor Therapeutics (CAPR) and Bathurst Resources (BRL). Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:IDX CIKN/A Webwww.integraldiagnostics.com.au Phone61 3 5339 0704FaxN/AEmployees2,010Year FoundedN/AProfitability EPS (Trailing Twelve Months)A($0.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E Growth1.39Net Income-A$60.70 million Net Margins-12.92% Pretax MarginN/A Return on Equity-20.16% Return on Assets3.36% Debt Debt-to-Equity Ratio118.59 Current Ratio0.86 Quick Ratio1.84 Sales & Book Value Annual SalesA$469.70 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow23.99 Book ValueA$1.29 per share Price / BookN/AMiscellaneous Outstanding Shares233,960,000Free FloatN/AMarket CapA$1.10 billion OptionableNot Optionable Beta0.73 The Best Nuclear Energy Stocks to BuyNuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.Get This Free Report This page (ASX:IDX) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Integral Diagnostics Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Integral Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
